(Q36031032)

11 August 2017

Inflammatory markers in antipsychotic-naïve patients with nonaffective psychosis and deficit vs. nondeficit features (English)

1 reference

Corrigendum to “Inflammatory markers in antipsychotic-naïve patients with nonaffective psychosis and deficit vs. nondeficit features” [Psychiatry Res. 198 (2012) 212–215]

11 August 2017

1 reference

corrigendum / erratum

1 reference

10.1016/J.PSYCHRES.2013.08.041

Crossref

DOI

12 July 2019

http://api.crossref.org/works?select=update-to&filter=doi:10.1016/J.PSYCHRES.2013.08.041

Azucena Justicia

4

0 references

Clemente Garcia-Rizo

object named as

Clemente Garcia-Rizo

1

0 references

Miguel Bernardo

object named as

Miguel Bernardo

5

0 references

Brian Kirkpatrick

6

object named as

Brian Kirkpatrick

0 references

author name string

Emilio Fernandez-Egea

2

1 reference

11 August 2017

Cristina Oliveira

3

1 reference

11 August 2017

language of work or name

English

0 references

publication date

8 March 2012

1 reference

11 August 2017

1 reference

11 August 2017

198

1 reference

11 August 2017

2

1 reference

11 August 2017

212-215

1 reference

Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374916

Celecoxib treatment in an early stage of schizophrenia: results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374916

Cytokines and CNS development

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374916

Metabolic profile of antipsychotic-naive individuals with non-affective psychosis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374916

Differences in glucose tolerance between deficit and nondeficit schizophrenia

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374916

Deficit schizophrenia: an update

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374916

Coagulation and inflammation markers during atypical or typical antipsychotic treatment in schizophrenia patients and drug-free first-degree relatives

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374916

Deficit schizophrenia: association with serum antibodies to cytomegalovirus

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374916

Circulating inflammatory markers and risks of cardiovascular and non-cardiovascular disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374916

COX-2 inhibitors as adjunctive therapy in schizophrenia

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374916

The stress cascade and schizophrenia: etiology and onset

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374916

Cellular and humoral immune system in schizophrenia: a conceptual re-evaluation

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374916

A separate disease within the syndrome of schizophrenia

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374916

Seasonality of births in schizophrenia and bipolar disorder: a review of the literature

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374916

The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374916

The deficit syndrome in the Suffolk County Mental Health Project.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374916

The Schedule for the Deficit syndrome: an instrument for research in schizophrenia.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374916

Psychopathology, coronary heart disease and metabolic syndrome in schizophrenia spectrum patients with deficit versus non-deficit schizophrenia: findings from the CLAMORS study.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374916

Genetic variants of IL-6 and its receptor are not associated with schizophrenia in Taiwan.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374916

Psychopathology and neuropsychological impairments in deficit and nondeficit schizophrenia of Chinese origin.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374916

Double dissociation of N1 and P3 abnormalities in deficit and nondeficit schizophrenia.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374916

Celecoxib as adjunctive therapy in schizophrenia: a double-blind, randomized and placebo-controlled trial

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374916

Elevated serum levels of C-reactive protein are associated with more severe psychopathology in a subgroup of patients with schizophrenia.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374916

Non-steroidal anti-inflammatory drugs and the risk of psychosis.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374916

Three dimensions of clinical symptoms in elderly patients with schizophrenia: prediction of six-year cognitive and functional status.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374916

The effects of celecoxib augmentation on cytokine levels in schizophrenia

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374916

Clinical effects of COX-2 inhibitors on cognition in schizophrenia.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374916

Summer birth and deficit schizophrenia: a pooled analysis from 6 countries

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374916

Neuroleptics modulate cytokine and reactive oxygen species production in blood leukocytes of healthy volunteers

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374916

Suspiciousness and alcohol use disorders in schizophrenia

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374916

Summer birth and deficit schizophrenia in the epidemiological catchment area study

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374916

A five-year followup study of deficit and nondeficit schizophrenia.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374916

The deficit syndrome in the DSM-IV Field Trial: I. Alcohol and other drug abuse

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374916

The Th2-hypothesis of schizophrenia: a strategy to identify a subgroup of schizophrenia caused by immune mechanisms

23 September 2018

1 reference

12 December 2020

Summer birth and the deficit syndrome of schizophrenia

1 reference

12 December 2020

Summer birth and deficit schizophrenia: Cantabria, Spain

1 reference

12 December 2020

The deficit syndrome in the DSM-IV Field Trial. Part II. Depressive episodes and persecutory beliefs

1 reference

12 December 2020

The course of cognitive functioning in first episode psychosis: changes over time and impact on outcome

1 reference

12 December 2020

Interleukin-6: the endocrine cytokine

1 reference

12 December 2020

Serum interleukin-6 concentration in schizophrenia: elevation associated with duration of illness

1 reference

12 December 2020

Family characteristics of deficit and nondeficit schizophrenia in the Roscommon Family Study

1 reference

12 December 2020

Summer birth and deficit schizophrenia in Dumfries and Galloway, southwestern Scotland

1 reference

12 December 2020

Substance abuse and the heterogeneity of schizophrenia a population-based study

1 reference

12 December 2020

Decreased serum levels of interleukin-2 and interleukin-6 in Indian Bengalee schizophrenic patients

1 reference

12 December 2020

Depressive symptoms and the deficit syndrome of schizophrenia

1 reference

12 December 2020

Case identification and stability of the deficit syndrome of schizophrenia

1 reference

12 December 2020

Serum levels of soluble IL-2 receptor alpha, IL-6 and IL-1 receptor antagonist in schizophrenia before and during neuroleptic administration

1 reference

12 December 2020

Association of blood levels of C-reactive protein with clinical phenotypes in Arab schizophrenic patients

1 reference

12 December 2020

Schizoid-like features and season of birth in a nonpatient sample

1 reference

12 December 2020

C-reactive protein is associated with the severity of cognitive impairment but not of psychiatric symptoms in individuals with schizophrenia

1 reference

12 December 2020

10.1016/J.PSYCHRES.2011.08.014

Identifiers

DOI

1 reference

release_3oulajugbna6bcaiyoupiynh7u

11 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3oulajugbna6bcaiyoupiynh7u

24 November 2022

mapped directly with Wikidata item

1 reference

11 August 2017

PubMed publication ID

22405656

1 reference